Advertisement Matrixx Confirms Voluntary Recall Of Zicam - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Matrixx Confirms Voluntary Recall Of Zicam

Disagrees with FDA's allegations that these products are unsafe and were unlawfully marketed

Matrixx has said that it is in the process of formally notifying retailers, wholesalers and distributors nationwide, of its recall of all Zicam Cold Remedy Nasal Gel and Zicam Cold Remedy Gel Swabs.

Matrixx disagrees with the FDA’s allegations that these products are not safe and were unlawfully marketed. However, the company has restated that it is conducting this recall because of its desire to cooperate with the FDA.

The company is also in the process of preparing a submission to the FDA. As previously reported, it will soon ask to meet with the agency to present comprehensive scientific and medical data and analyses, demonstrating that these products are safe.